These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1162343)

  • 21. Dose-response analysis of the enhancement of liver tumour formation in CF-1 mice by dieldrin.
    Tennekes HA; Edler L; Kunz HW
    Carcinogenesis; 1982; 3(8):941-5. PubMed ID: 7127675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of dieldrin and phenobarbital on preneoplastic hepatic lesion growth in male F344 rat and B6C3F1 mouse.
    Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
    Prog Clin Biol Res; 1995; 391():409-23. PubMed ID: 8532733
    [No Abstract]   [Full Text] [Related]  

  • 23. Environmental determinants of human cancer.
    Epstein SS
    Cancer Res; 1974 Oct; 34(10):2425-35. PubMed ID: 4606519
    [No Abstract]   [Full Text] [Related]  

  • 24. Biologic evidence for the existence of thesholds in chemical carcinogenesis.
    Falk HL
    Environ Health Perspect; 1978 Feb; 22():167-70. PubMed ID: 648485
    [No Abstract]   [Full Text] [Related]  

  • 25. A carcinogenicity study of pesticide dieldrin in hamsters.
    Cabral JR; Hall RK; Bronczyk SA; Shubik P
    Cancer Lett; 1979 Apr; 6(4-5):241-6. PubMed ID: 436118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversibility of promoter induced hepatic focal lesion growth in mice.
    Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
    Carcinogenesis; 1996 Jul; 17(7):1403-9. PubMed ID: 8706241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoplastic response of mouse tissues during perinatal age periods and its significance in chemical carcinogenesis.
    Vesselinovitch SD; Rao KV; Mihailovich N
    Natl Cancer Inst Monogr; 1979 May; (51):239-50. PubMed ID: 384263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proposal: a non-zero approach to environmental limits for carcinogens.
    Flowers ES
    Occup Health Saf; 1977; 46(3):35-9. PubMed ID: 194189
    [No Abstract]   [Full Text] [Related]  

  • 29. Carcinogenicity of organic fractions of particulate pollutants collected in New York City and administered subcutaneously to infant mice.
    Asahina S; Andrea J; Carmel A; Arnold E; Bishop Y; Joshi S; Coffin D; Epstein SS
    Cancer Res; 1972 Oct; 32(10):2263-8. PubMed ID: 4343014
    [No Abstract]   [Full Text] [Related]  

  • 30. Waiting for a philosopher king: making cancer policy until certainty arrives.
    Speth G
    Tex Rep Biol Med; 1978; 37():95-106. PubMed ID: 752987
    [No Abstract]   [Full Text] [Related]  

  • 31. The need for quantifying risk from exposures to chemical carcinogens.
    Flamm WG
    Prev Med; 1976 Mar; 5(1):4-6. PubMed ID: 1264968
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective dieldrin promotion of hepatic focal lesions in mice.
    Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
    Carcinogenesis; 1996 Jun; 17(6):1243-50. PubMed ID: 8681438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative aspects of enhanced liver tumour formation in CF-1 mice by dieldrin.
    Tennekes H; van Ravenzwaay B; Kunz HW
    Carcinogenesis; 1985 Oct; 6(10):1457-62. PubMed ID: 4042275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Mouse data.
    Hunt PF; Stevenson DE; Thorpe E; Walker AI
    Food Cosmet Toxicol; 1975 Oct; 13(5):597-9. PubMed ID: 1201838
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of human exposures to selected chemicals with thresholds from NTP carcinogenicity studies in rodents.
    Waddell WJ
    Hum Exp Toxicol; 2003 Sep; 22(9):501-6. PubMed ID: 14580010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kinetics of nuclear polyploidization and tumour formation in livers of CF-1 mice exposed to dieldrin.
    van Ravenzwaay B; Tennekes H; Stöhr M; Kunz W
    Carcinogenesis; 1987 Feb; 8(2):265-9. PubMed ID: 3802410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of human cancer potency projections for dieldrin based on human data with those based on animal data.
    Sielken RL; Stevenson DE
    Prog Clin Biol Res; 1992; 374():295-319. PubMed ID: 1620708
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Estimating "safe" levels, a hazardous undertaking.
    Bross ID
    Cancer Res; 1975 Nov; 35(11 Pt 1):3212-3. PubMed ID: 1182708
    [No Abstract]   [Full Text] [Related]  

  • 40. Standards for the control of carcinogens in the workplace.
    Rose VE
    J Occup Med; 1976 Feb; 18(2):81-4. PubMed ID: 1249665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.